OSR HEALTH, INC. Investing Cash Flow
OSR HEALTH, INC. (OSRH) reported Investing Cash Flow of -$76.65 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-14
- OSR HEALTH, INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$88.33K.
- OSR HEALTH, INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $11.68K, a 99.02% decline year-over-year.
- OSR HEALTH, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$2.57M.
- OSR HEALTH, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$726.63K, a 396.31% decline year-over-year.
- OSR HEALTH, INC. net cash provided by (used in) investing activities for fiscal 2025 was -$2.64M, a 624.81% decline from fiscal 2024.
- OSR HEALTH, INC. net cash provided by (used in) investing activities for fiscal 2024 was $503.61K.
- OSR HEALTH, INC. net cash provided by (used in) investing activities for fiscal 2023 was -$33.83M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 3 month as first filed | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 6 month as first filed | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$88.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$76.65K 10-Q · filed 2026-08-14 | -$2.65M derived: sum of 3 quarters · filed 2026-08-14 | -$3.38M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $11.68K 10-Q · filed 2026-05-13 | -$2.56M derived: sum of 2 quarters · filed 2026-05-13 | -$3.29M derived: sum of 3 quarters · filed 2026-05-13 | -$3.82M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | -$2.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$3.30M derived: sum of 2 quarters · filed 2026-03-31 | -$3.83M derived: sum of 3 quarters · filed 2026-08-14 | -$2.64M 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | -$726.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$1.26M derived: sum of 2 quarters · filed 2026-08-14 | -$69.47K 10-Q · filed 2025-11-12 | -$257.28K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | -$528.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $657.17K 10-Q · filed 2026-08-14 | $469.36K derived: sum of 3 quarters · filed 2026-08-14 | $714.59K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | $1.19M 10-Q · filed 2026-05-13 | $1.19M 10-Q · filed 2025-05-20 | $997.78K derived: sum of 2 quarters · filed 2026-05-13 | $1.24M derived: sum of 3 quarters · filed 2026-05-13 | $1.46M derived: sum of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | -$187.81K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $57.42K derived: sum of 2 quarters · filed 2026-03-31 | $276.98K derived: sum of 3 quarters · filed 2026-03-31 | $503.61K 10-K · filed 2026-03-31 | $35.91M 10-K · filed 2025-04-22 | |||
| 2024-09-30 | $245.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $464.79K derived: sum of 2 quarters · filed 2025-11-12 | $691.42K 10-Q · filed 2025-11-12 | $16.93M 10-Q · filed 2024-11-14 | $37.07M derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | $219.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $446.19K 10-Q · filed 2025-08-14 | $17.08M 10-Q · filed 2024-08-19 | $36.82M derived: sum of 3 quarters · filed 2025-08-14 | $36.82M derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | $226.63K 10-Q · filed 2025-05-20 | -$120.00K 10-Q · filed 2024-05-15 | $36.60M derived: sum of 2 quarters · filed 2025-05-20 | $36.60M derived: sum of 3 quarters · filed 2025-05-20 | $36.60M derived: sum of 4 quarters · filed 2025-05-20 | |||
| 2023-12-31 | $36.38M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-22 | $36.38M derived: sum of 2 quarters · filed 2025-04-22 | $36.38M derived: sum of 3 quarters · filed 2025-04-22 | -$33.83M 10-K · filed 2025-04-22 | ||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | -$70.21M 10-Q · filed 2024-11-14 | |||||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | -$70.21M 10-Q · filed 2024-08-19 | ||||||
| 2023-03-31 | -$70.21M 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |